Showing results (1211-1220 of 31,365) with videos related to
Sort By:
Pageof 3,137
Journal of Medicinal Chemistry|October 16, 2004
A comparison of methods for modeling quantitative structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F WeaverJournal of Medicinal Chemistry|October 16, 2004
New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugsCarmen Almansa, Javier Bartrolí, Jordi Belloc, et al.Journal of Medicinal Chemistry|October 16, 2004
Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13)Holger Bittermann, Jürgen Einsiedel, Harald Hübner, et al.Journal of Medicinal Chemistry|November 13, 2004
Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridizationJia Zhou, Rong He, Kenneth M Johnson, et al.Journal of Medicinal Chemistry|November 13, 2004
An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing propertiesMark S Chambers, John R Atack, Robert W Carling, et al.Journal of Medicinal Chemistry|November 13, 2004
Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxidaseThomas C Rosen, Shinichi Yoshida, Roland Fröhlich, et al.Journal of Medicinal Chemistry|November 13, 2004
Improved structure-activity relationship analysis of HIV-1 protease inhibitors using interaction kinetic dataCynthia F Shuman, Lotta Vrang, U Helena DanielsonJournal of Medicinal Chemistry|November 13, 2004
5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarialsChristophe Biot, Holger Bauer, R Heiner Schirmer, et al.Journal of Medicinal Chemistry|November 13, 2004
Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocksChihae Yang, Kevin Cross, Glenn J Myatt, et al.Journal of Medicinal Chemistry|November 13, 2004
Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressinWioleta Kowalczyk, Adam Prahl, Izabela Derdowska, et al.Pageof 3,137